Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China
- PMID: 39370830
- DOI: 10.1002/jmv.29858
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China
Abstract
The COVID-19 pandemic had a significant impact on the global influenza vaccination and the epidemics of seasonal influenza. To further explore the molecular epidemiology of influenza viruses and assess vaccine effectiveness, we collected influenza cases in Wuhan during the 2022-2023 influenza season. Among 1312 clinical samples, 312 samples tested positive for influenza viruses using reverse transcription polymerase chain reaction. These positive samples included 146A/H1N1 subtypes (46.8%), 164A/H3N2 subtypes (52.6%) and 2 influenza B virus types (0.6%). Based on the whole genome sequence information of hemagglutinin (HA) and neuraminidase (NA) from 27A/H1N1 influenza virus strains and 26A/H3N2 influenza virus strains obtained in this study, a phylogenetic analysis was conducted. The analysis revealed that all A/H1N1 strains belonged to the evolutionary branch 6B.1A.5a.2a, and they exhibited specific substitutions at positions K71Q, Q206E, E241A, and R276K. Similarly, all A/H3N2 strains were classified into the 3C.2a1b.2a.1a subclade and displayed amino acid substitutions at positions S172H, N175Y, I176T, K187N, and S214P. Notably, the A/H3N2 strains also acquired a new potential glycosylation site at position N174. Using an epitope model, the predicted vaccine effectiveness was assessed for the A/H1N1 and A/H3N2 strains. The predicted vaccine effectiveness against the Wuhan influenza epidemic strain was over 85% for the A/H1N1 vaccine strain. However, the effectiveness against the A/H3N2 vaccine strain was only 48.7%. To further verify the protection of influenza vaccine against circulating influenza viruses in the region, we conducted in vivo and in vitro animal studies. The results of in vitro neutralization experiment showed that rabbit serum antibodies inoculated with quadrivalent isolated influenza vaccine had neutralization ability against all 24 isolated influenza viruses. In vivo experiments showed that vaccinated mice had fewer lung lesions when infected with the influenza strain circulating in Wuhan, suggesting that vaccination can effectively reduce the occurrence of severe lung damage. These findings emphasize the importance of accurately predicting seasonal influenza strains for effective influenza prevention and control, especially during the co-circulation of SARS-CoV-2 and influenza viruses. This study provides valuable information on the seasonal influenza virus in Wuhan during the COVID-19 pandemic and serves as a basis for vaccine prediction and updates.
Keywords: influenza A virus; molecular epidemiology; phylogenic analysis; vaccine effectiveness.
© 2024 Wiley Periodicals LLC.
Similar articles
-
Resurgence of influenza with increased genetic diversity of circulating viruses during the 2022-2023 season.J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001864. J Med Microbiol. 2024. PMID: 39073070
-
Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.J Med Microbiol. 2020 Jul;69(7):986-998. doi: 10.1099/jmm.0.001198. J Med Microbiol. 2020. PMID: 32459617 Free PMC article.
-
Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019-2020 winter season.Virus Genes. 2021 Oct;57(5):401-412. doi: 10.1007/s11262-021-01853-w. Epub 2021 Jun 22. Virus Genes. 2021. PMID: 34156583 Free PMC article.
-
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.Hum Vaccin Immunother. 2018;14(8):1840-1847. doi: 10.1080/21645515.2018.1462639. Epub 2018 May 14. Hum Vaccin Immunother. 2018. PMID: 29641358 Free PMC article. Review.
-
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine.Drugs. 2024 Sep;84(9):1013-1023. doi: 10.1007/s40265-024-02083-8. Epub 2024 Aug 21. Drugs. 2024. PMID: 39167316 Free PMC article. Review.
Cited by
-
Epidemiological trends of influenza A and B in one hospital in Chengdu and national surveillance data (2019-2024).Front Cell Infect Microbiol. 2025 Jun 12;15:1603369. doi: 10.3389/fcimb.2025.1603369. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40575488 Free PMC article.
References
REFERENCES
-
- Hutchinson EC. Influenza virus. TIM. 2018;26(9):809‐810. doi:10.1016/j.tim.2018.05.013
-
- Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza‐associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285‐1300. doi:10.1016/S0140-6736(17)33293-2
-
- Baselga‐Moreno V, Trushakova S, McNeil S, et al. Influenza epidemiology and influenza vaccine effectiveness during the 2016‐2017 season in the Global Influenza Hospital Surveillance Network (GIHSN). BMC Public Health. 2019;19(1):487. doi:10.1186/s12889-019-6713-5
-
- D'angiolella LS, Lafranconi A, Cortesi PA, Rota S, Cesana G, Mantovani LG. Costs and effectiveness of influenza vaccination: a systematic review. Ann Ist Super Sanita. 2018;54(1):49‐57. doi:10.4415/ANN_18_01_10
-
- Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices ‐ United States, 2022‐23 influenza season. MMWR Recomm Rep. 2022;71(1):1‐28. doi:10.15585/mmwr.rr7101a1
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous